Sports medicine

What if flat feet were…normal? Debunking a myth about injuries

Retrieved on: 
Tuesday, April 23, 2024

Specifically, having flat feet was believed to predispose individuals to future pain and other musculoskeletal problems (i.e.

Key Points: 
  • Specifically, having flat feet was believed to predispose individuals to future pain and other musculoskeletal problems (i.e.
  • Flat feet were believed to be a kind of time bomb.
  • We demonstrate that the theory that having flat feet inevitably leads to pain or other musculoskeletal problems, is unfounded.

Where does this theory come from?

  • This theory became central to the educational programs of health professionals.
  • In fact, science has never validated the theory: it has remained at the hypothesis stage.
  • Nevertheless, over the years up until the present, many health professionals have continued to support the theory that flat feet pose a major risk for developing musculoskeletal disorders.

Do flat feet cause musculoskeletal injuries?

  • Furthermore, a systematic review and a meta-analysis concluded that runners with flat feet are no more at risk of injury than those with regular feet.
  • These analyses call into question the idea that people with flat feet have a substantial risk of developing musculoskeletal disorders.
  • Unfortunately, this frequently results in people having unnecessary interventions, such as using orthopaedic shoes or custom-made foot orthoses for asymptomatic flat feet.

Setting the record straight

  • Based on current scientific knowledge, assessing whether a person has flat feet to determine their risk of injury is ineffective and counterproductive.
  • While it is possible for a person with flat feet to develop a musculoskeletal injury, this does not necessarily mean that flat feet caused the injury.
  • It is quite possible for two variables to be present at the same time without there being a causal link.
  • A cause-and-effect relationship implies that a change in one variable (the cause) leads to a change in another variable (the effect).

Reducing overdiagnosis in health care

  • Reducing overdiagnosis in health care has become crucial.
  • Since overdiagnosis often leads to overtreatment, avoiding unnecessary treatments will help to alleviate patients’ concerns about their flat feet.
  • It’s time to change our perspective and our approach to the significance of flat feet and to recognize their natural diversity in the context of overall foot health.


Gabriel Moisan is a member of the Ordre des Podiatres du Québec (College of Podiatrists Québec). He has received funding from the Natural Sciences and Engineering Research Council of Canada (NSERC), the War Amps of Canada and the Réseau provincial de recherche en adaptation-réadaptation (REPAR).

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA

Retrieved on: 
Wednesday, April 3, 2024

PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology.

Key Points: 
  • PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology.
  • Spryng is an intra-articular injectable veterinary medical device composed of sterilized, extra-cellular matrix microparticles.
  • The microparticles of Spryng have been found to adsorb onto the joint synovial lining of animals and subsequently integrate with the animal’s subsynovial tissue.
  • Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of noninfectious sources of joint pain such as joint instability, degenerative joint disease and osteoarthritis.

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN CHARLESTON, SOUTH CAROLINA

Retrieved on: 
Wednesday, April 3, 2024

PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology.

Key Points: 
  • PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology.
  • Spryng is an intra-articular injectable veterinary medical device composed of sterilized, extra-cellular matrix microparticles.
  • The microparticles of Spryng have been found to adsorb onto the joint synovial lining of animals and subsequently integrate with the animal’s subsynovial tissue.
  • Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of noninfectious sources of joint pain such as joint instability, degenerative joint disease and osteoarthritis.

Global Sports Medicine Devices Market Set for Significant Growth, Poised to Reach $11 Billion by 2028 Driven by Technological Advances and Injury Prevention Trends - Long-term Forecast to 2033 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 9, 2024

The global market for sports medicine devices has observed a robust expansion in recent years, with projections indicating a continued trajectory of growth.

Key Points: 
  • The global market for sports medicine devices has observed a robust expansion in recent years, with projections indicating a continued trajectory of growth.
  • The sector is forecasted to burgeon from $7.44 billion in 2023 to an estimable $8.06 billion in 2024.
  • As we look toward the future, the market is set to reach new heights, expected to achieve $11 billion by 2028, growing at a steady CAGR of 8.1%.
  • Innovation remains at the forefront of the sports medicine device market with leading companies at the helm of technological breakthroughs.

Orthobond Secures De Novo Classification Grant for First-in-Class Antibacterial Surface Treatment Applied to a Spinal Device

Retrieved on: 
Monday, April 8, 2024

Orthobond Corporation , a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, announced today that the U.S. Food and Drug Administration (FDA) granted its De Novo marketing request for the use of Ostaguard™, its proprietary antibacterial surface treatment, on a permanent medical device.

Key Points: 
  • Orthobond Corporation , a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, announced today that the U.S. Food and Drug Administration (FDA) granted its De Novo marketing request for the use of Ostaguard™, its proprietary antibacterial surface treatment, on a permanent medical device.
  • Numerous studies have shown between 70-100% of explanted hardware from failed joint implants have some level of contamination from different sources.
  • Orthobond pioneered a method to covalently-bond its antibacterial molecule to the surface of implants.
  • The proprietary surface technology is applied during the manufacturing process prior to packaging and sterilization.

BON SECOURS MERCY HEALTH AND COMPASS SURGICAL PARTNERS ANNOUNCE GRAND OPENING OF WORLD-CLASS SURGERY CENTER IN GREENVILLE, SOUTH CAROLINA

Retrieved on: 
Tuesday, April 9, 2024

GREENVILLE, S.C. and RALEIGH, N.C., April 9, 2024 /PRNewswire/ -- Millennium Surgery Center, a joint venture between Bon Secours Mercy Health, Compass Surgical Partners (Compass) and local physicians, today announced that it will launch in Greenville, South Carolina, with a grand opening on April 11.

Key Points: 
  • GREENVILLE, S.C. and RALEIGH, N.C., April 9, 2024 /PRNewswire/ -- Millennium Surgery Center, a joint venture between Bon Secours Mercy Health, Compass Surgical Partners (Compass) and local physicians, today announced that it will launch in Greenville, South Carolina, with a grand opening on April 11.
  • Located at 214 Innovation Drive in Greenville, South Carolina, the 20,000-square-foot facility will host a ribbon cutting ceremony on April 11 at 12pm.
  • Millennium Surgery Center expects to secure accreditation from the Accreditation Association for Ambulatory Health Care and certification from Medicare by mid-May.
  • The newly developed facility is the fourth opened thus far through the strategic partnership between Bon Secours Mercy Health and Compass.

Parker University Announces the Accreditation of its Master of Science in Strength and Human Performance Program

Retrieved on: 
Monday, March 25, 2024

Parker University is proud to announce that its graduate-level Strength and Conditioning program has been granted five years of initial accreditation status!

Key Points: 
  • Parker University is proud to announce that its graduate-level Strength and Conditioning program has been granted five years of initial accreditation status!
  • Parker University’s Strength and Human Performance Program Director Jenna Romanelli, MS, Med, RD, CSC, says, “The CASCE accreditation directly reflects our Strength and Human Performance degree.
  • Parker University’s degrees in Strength and Human Performance provide students with an expansive study of evidence-based research in physiology, biomechanics, and human metabolism to enhance health, function, and physical performance.
  • Parker University is proud of its unwavering dedication to providing strength and conditioning education of the highest quality.

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

Retrieved on: 
Monday, March 25, 2024

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports.

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports.
  • “We’re thrilled to have Smith+Nephew join us for the first time as an Official UFC Partner,” said Robby Miller, Vice President, UFC Global Partnerships.
  • “Through hard work, significant investment, and groundbreaking innovations like the UFC Performance Institute, UFC has become the industry leader in athlete health and safety in combat sports.
  • We are proud to partner with UFC and share a common goal to get patients back in the game quickly, safely, and effectively,” said Scott Schaffner, President Sports Medicine, Smith+Nephew.

A-GAME Announces Appointment of Thomas Bond, MD, MS as Chief Medical Officer

Retrieved on: 
Thursday, March 21, 2024

ORLANDO, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- A-GAME Beverages Inc. (“A-GAME”), creator of the “ultimate” hydration beverage, is pleased to announce the appointment of Dr. Thomas Bond as Chief Medical Officer.

Key Points: 
  • ORLANDO, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- A-GAME Beverages Inc. (“A-GAME”), creator of the “ultimate” hydration beverage, is pleased to announce the appointment of Dr. Thomas Bond as Chief Medical Officer.
  • Bond will act as the first Chief Medical Officer for A-GAME Beverages and bring years and valuable experience of both clinical and sideline expertise in the field of Sports Medicine.
  • Dr.
  • Bond was recruited to LSU Medical Center in New Orleans as the Chief of Sports Medicine.

Penn Highlands Healthcare Doctors Beyond the Borders

Retrieved on: 
Wednesday, March 20, 2024

Penn Highlands Healthcare offers 849 physicians who provide a wide range of care and treatments at locations throughout 26 counties in Pennsylvania.

Key Points: 
  • Penn Highlands Healthcare offers 849 physicians who provide a wide range of care and treatments at locations throughout 26 counties in Pennsylvania.
  • Penn Highlands Healthcare physicians can be found in the health system’s eight hospitals as well as many community medical buildings, outpatient facilities, surgery centers and physician practices.
  • Some Penn Highlands Healthcare physicians do not allow county, state or continental borders to keep them from providing care where it is needed.
  • Dr. Sergent, who is an emergency medicine physician and the Central Region Medical Director of Emergency Medicine at Penn Highlands Healthcare, shares his skills and expertise beyond the U.S. borders in Central and South America.